DGAP-News: Biotest AG
/ Key word(s): Miscellaneous
20.07.2021 / 07:00
The issuer is solely responsible for the content of this announcement.
Biotest AG opens 11th plasma collection centre in Hungary
– 25 plasma collection centres in Europe to ensure long-term plasma supply
Dreieich, 20 July 2021. Biotest received an operating permit for its 11th plasma collection centre in Hungary from the country’s national public health authority OTH. The centre is located in a shopping centre in the north-western Hungarian university town of Sopron and is one of the most modern in Europe. The centre, equipped with 20 donor beds, has created 24 new jobs in Sopron. Thus, the company is further expanding its plasma collection capacity and is safeguarding the plasma supply to future growth.
The first plasma collection centre in Budapest was opened in 2009 by Plazmaszolgálat Kft., a 100% subsidiary of Biotest AG. “We are very pleased to open another state-of-the-art collection centre in Hungary. I would like to express my gratitude once again to all plasma donors and also to our dedicated employees. Only in this way is Biotest able to produce sufficient quantities of the life-saving medicines even in the pandemic under very difficult conditions,” emphasises Dr Frank Velte, Vice President Plasma Service Europe GmbH.
The collected plasma is processed only by Biotest AG at Dreieich, Germany. Regular audits in Hungary ensure that the strict legal and internal quality requirements are met.
About human blood plasma
Biotest AG, Landsteinerstr. 5, 63303 Dreieich, Germany, www.biotest.com
Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||0 61 03 – 8 01-0|
|Fax:||0 61 03 – 8 01-150|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1219747|
|End of News||DGAP News Service|